{
    "startDate": "2021-01-01",
    "endDate": "2021-12-31",
    "year": "2021",
    "quarter": "FY",
    "symbol": "TMB",
    "data": {
        "bs": [
            {
                "label": "Preferred stock ($0.0001 par value), 2,000,000 shares authorized, 250,000 shares of Class A preferred stock issued and outstanding as of December 31, 2021 and 2020, respectively",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "mbio:PropertyPlantAndEquipmentExcludingAssetsUnderConstruction",
                "unit": "usd",
                "value": 9025000
            },
            {
                "label": "Common stock issuable, 2,607,981 and 2,103,122 shares as of December 31, 2021 and 2020, respectively",
                "concept": "CommonStockSharesSubscriptions",
                "unit": "usd",
                "value": 4329000
            },
            {
                "label": "Other receivables - related party",
                "concept": "OtherReceivables",
                "unit": "usd",
                "value": 50000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashNoncurrent",
                "unit": "usd",
                "value": 1000000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 111706000
            },
            {
                "label": "Deferred income",
                "concept": "DeferredIncomeNoncurrent",
                "unit": "usd",
                "value": 270000
            },
            {
                "label": "Total Liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 12770000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 10815000
            },
            {
                "label": "Fixed assets - construction in process",
                "concept": "mbio:ConstructionInProcessNet",
                "unit": "usd",
                "value": 2027000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 109618000
            },
            {
                "label": "Operating lease liabilities - short-term",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 348000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 9744000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 9744000
            },
            {
                "label": "Operating lease liabilities - long-term",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 1685000
            },
            {
                "label": "Payables and accrued expenses - related party",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 723000
            },
            {
                "label": "Operating lease right-of-use asset, net",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 1050000
            },
            {
                "label": "Operating lease right-of-use asset, net",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 1100000.0
            },
            {
                "label": "Commitments and Contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 125170000
            },
            {
                "label": "Total Stockholders' Equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 112400000
            },
            {
                "label": "Total Stockholders' Equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 112400000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -251844000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -251800000.0
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 359906000
            },
            {
                "label": "Total Liabilities and Stockholders' Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 125170000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 2038000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 362000
            }
        ],
        "cf": [
            {
                "label": "Common shares issuable for Founders Agreement",
                "concept": "mbio:AdjustmentToRecognizeEffectOfResearchAndDevelopmentExpenseAttributableToAssetAcquiredViaStockIssuance",
                "unit": "usd",
                "value": 4212000
            },
            {
                "label": "Proceeds from issuance of common shares under ESPP",
                "concept": "ProceedsFromStockPlans",
                "unit": "usd",
                "value": 309000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Lease liabilities arising from obtaining right-of-use assets",
                "concept": "mbio:LeaseLiabilitiesArisingFromObtainingRightOfUseAssets",
                "unit": "usd",
                "value": 101000
            },
            {
                "label": "Purchase of research and development licenses",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 1380000
            },
            {
                "label": "Offering costs for the issuance of common shares - Public Offering",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Depreciation expense",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 2167000
            },
            {
                "label": "Depreciation expense",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 2200000.0
            },
            {
                "label": "Other receivables - related party",
                "concept": "IncreaseDecreaseInOtherReceivables",
                "unit": "usd",
                "value": 35000
            },
            {
                "label": "Accretion of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Research and development - licenses acquired",
                "concept": "mbio:ResearchAndDevelopmentLicenseInAccountsPayableAndAccruedExpense",
                "unit": "usd",
                "value": 1630000
            },
            {
                "label": "Offering costs for the issuance of common shares - At-the-Market Offering, in accounts payable and accrued expenses",
                "concept": "mbio:OfferingCostsForIssuanceOfCommonSharesAtMarketOfferingInAccountsPayableAndAccruedExpenses",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 401000
            },
            {
                "label": "Proceeds from issuance of common shares - At-the-Market Offering",
                "concept": "mbio:ProceedsFromIssuanceOfCommonSharesAtMarketOffering",
                "unit": "usd",
                "value": 71919000
            },
            {
                "label": "Payable and accrued expenses - related party",
                "concept": "IncreaseDecreaseInDueToRelatedParties",
                "unit": "usd",
                "value": 233000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -66370000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -66370000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -66370000
            },
            {
                "label": "Issuance of common shares - Founders Agreement",
                "concept": "StockIssued1",
                "unit": "usd",
                "value": 7577000
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -5366000
            },
            {
                "label": "Repayment of notes payable",
                "concept": "RepaymentsOfRelatedPartyDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Amortization of operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAssetAmortizationExpense",
                "unit": "usd",
                "value": 139000
            },
            {
                "label": "Lease liabilities",
                "concept": "mbio:IncreaseDecreaseInLeaseLiabilities",
                "unit": "usd",
                "value": 296000
            },
            {
                "label": "Issuance of common shares - Equity fee on Public Offering to Fortress Biotech",
                "concept": "mbio:IssuanceOfCommonSharesEquityFeeOnPublicOffering",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Fixed assets (acquired but not paid)",
                "concept": "CapitalExpendituresIncurredButNotYetPaid",
                "unit": "usd",
                "value": 1270000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -53667000
            },
            {
                "label": "Net change in cash, cash equivalents and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": 11814000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "mbio:IncreaseDecreaseInAccountsPayableAndAccruedExpensesExcludingAmountsDueToRelatedParties",
                "unit": "usd",
                "value": -408000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 70847000
            },
            {
                "label": "Research and development licenses included in accounts payable and accrued expenses",
                "concept": "mbio:ResearchAndDevelopmentLicensesExpenditureIncurredButNotYetPaid",
                "unit": "usd",
                "value": 250000
            },
            {
                "label": "Issuance of common shares - Equity fee on At-the-Market Offering to Fortress Biotech",
                "concept": "mbio:IssuanceOfCommonSharesEquityFeeOnAtMarketOffering",
                "unit": "usd",
                "value": 1884000
            },
            {
                "label": "Purchase of fixed assets",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 3986000
            },
            {
                "label": "Offering costs for the issuance of common shares - At-the-Market Offering",
                "concept": "mbio:OfferingCostsForIssuanceOfCommonSharesAtMarketOffering",
                "unit": "usd",
                "value": 1381000
            },
            {
                "label": "Proceeds from issuance of common shares - Public Offering",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Stock-based compensation expenses",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 3308000
            },
            {
                "label": "Stock-based compensation expenses",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 3308000
            },
            {
                "label": "Deferred income",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": 270000
            }
        ],
        "ic": [
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 66723000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 11017000
            },
            {
                "label": "Interest expense",
                "concept": "OtherNonoperatingExpense",
                "unit": "usd",
                "value": 15000
            },
            {
                "label": "Interest income",
                "concept": "OtherNonoperatingIncome",
                "unit": "usd",
                "value": 368000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 49864000
            },
            {
                "label": "Research and development - licenses acquired",
                "concept": "ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
                "unit": "usd",
                "value": 5842000
            },
            {
                "label": "Weighted average number of common shares outstanding, basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 87885235
            },
            {
                "label": "Net Loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -66370000
            },
            {
                "label": "Net Loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -66370000
            },
            {
                "label": "Net Loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -66370000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -66723000
            },
            {
                "label": "Total other income (expense)",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 353000
            },
            {
                "label": "Net loss per common share outstanding, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.76
            }
        ]
    }
}